MadeAi validated its graph-inference capability across seven visual formats, achieving approximately 98% accuracy on graph and chart-inferred values with 99% traced to the exact figure and supporting source sentence.
Public source
Publisher name
Public post
Important clinical evidence is often locked inside figures, not written in the text. Which chart type is the most difficult and time-consuming for your team to extract d…
Company
MadeAi
Accelerating evidence synthesis with AI you can trust
- Industry
- Software Development
- Location
- Cambridge, US
- Company size
- 11–50 employees
About MadeAi
MadeAi™, developed by CapeStart, is an AI platform that streamlines life sciences evidence synthesis workflows. Its flagship solution, MadeAi-LR, accelerates literature reviews by up to 60% while maintaining over 90% accuracy. MadeAi enables additional evidence synthesis workflows including GVDs, MIRs, CERs, and JCA assistance, among others. The platform combines advanced machine learning with human validation to ensure FDA and EMA compliance. MadeAi is headquartered in Cambridge, Massachusetts and supported by CapeStart’s global team of 600+ professionals.
See moreLatest activity
Latest activity from MadeAi
9 signals
Presence & Recognition
MadeAi is attending the BioTechX USA 2026 conference in Boston from September 29 to 30 at the Hynes Convention Center.
Research & Knowledge
MadeAi tested its graph-inference capability through expert validation, reviewing 7 chart and graph formats, 81 graph-inferred data points, and achieving approximately 98% accuracy.
Presence & Recognition
MadeAi won the 2026 Fierce AI Innovation Award for its new AI-assisted Risk of Bias feature.
Discover more
Similar signals
Similar public activity from other companies.
Technology & Infrastructure
LandingAI
LandingAI demonstrated that 27 complex invoices became 494 Snowflake rows in 73 seconds using an end-to-end pipeline powered by the DPT-3 model.
Technology & Infrastructure
fileAI
fileAI automated Cemcoa's finance operations by extracting and matching bank statements and expense claims in one run across four bank formats, flagging exceptions before downstream entries.
Technology & Infrastructure
NyquistAI
NyquistAI developed an AI agent that monitors FDA and automatically provides a granular comparison of new and previous versions of regulatory guidances.
Technology & Infrastructure
Nutrient
Nutrient offers make-pdf and remediate-pdf skills for AI agents to create new PDFs or add accessibility structure to existing ones and check the result before downstream processing.
Research & Knowledge
Jedify